Paroxetine Hydrochloride

20Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Paroxetine hydrochloride (3. S-. trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3. S,4. R)-(4-(. p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotonin reuptake inhibitor. Paroxetine is indicated for the treatment of depression, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, and social anxiety disorder. The physicochemical properties, spectroscopic data (1D and 2D NMR, UV, FT-IR, MS, PXRD), stability, methods of preparation and chromatographic methods of analysis of pharmaceutical, and biological samples of paroxetine are documented in this review. Pharmacokinetics, metabolism, and pharmacological effects are also discussed. © 2013 Elsevier Inc.

Cite

CITATION STYLE

APA

Germann, D., Ma, G., Han, F., & Tikhomirova, A. (2013). Paroxetine Hydrochloride. In Profiles of Drug Substances, Excipients and Related Methodology (Vol. 38, pp. 367–406). Academic Press Inc. https://doi.org/10.1016/B978-0-12-407691-4.00008-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free